BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32141512)

  • 1. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.
    Sung NJ; Kim NH; Bae NY; Jo HS; Park SA
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
    Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
    Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
    Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
    Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gremlin1 promotes carcinogenesis of glioma in vitro.
    Guan Y; Cheng W; Zou C; Wang T; Cao Z
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
    Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
    Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
    Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
    BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells.
    Che D; Zhou T; Lan Y; Xie J; Gong H; Li C; Feng J; Hong H; Qi W; Ma C; Wu Q; Yang X; Gao G
    Int J Mol Med; 2016 Dec; 38(6):1815-1822. PubMed ID: 27748912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
    Yan T; Jiang X; Guo X; Chen W; Tang D; Zhang J; Zhang X; Zhang D; Zhang Q; Jia J; Huang Y
    J Dermatol Sci; 2017 Feb; 85(2):96-105. PubMed ID: 27919618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
    Sun X; Chang X; Wang Y; Xu B; Cao X
    Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin V Inhibits Migration and Invasion via Suppressing Snail/Slug-Mediated Epithelial-Mesenchymal Transition Progression in Human Breast Cancer MDA-MB-231 Cells In Vitro.
    Lin S; Zhang C; Liu F; Ma J; Jia F; Han Z; Xie W; Li X
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31137656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes aristolochic acid-induced epithelial-to-mesenchymal transition (EMT) in HK-2 cells.
    Li Y; Wang Z; Wang S; Zhao J; Zhang J; Huang Y
    Toxicology; 2012 Jul; 297(1-3):68-75. PubMed ID: 22525892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
    Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
    J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.